Epidemiology and one-year outcomes in patients with chronic heart failure and preserved, mid-range and reduced ejection fraction: an analysis of the ESC Heart Failure Long-Term Registry

Chioncel, Ovidiu, Lainscak, Mitja, Seferovic, Petar M., Anker, Stefan D., Crespo-Leiro, Maria G., Harjola, Veli-Pekka, Parissis, John, Laroche, Cecile +10 more·2017·European Journal of Heart Failure

Cited by (930)

Items 501–600 of 930

  1. Left ventricular function and coronary microcirculation in patients with mild reduced ejection fraction after STEMI
    Yuliang Ma, Lan Wang, Wenying Jin, Tiangang Zhu, Jian Liu, Hong Zhao, Jing Wang, Mingyu Lu, Cheng-fu CAO, Bailin Jiang · 2022 · BMC Cardiovascular Disorders
  2. High serum fibroblast growth factor 21 levels were related to the prognosis and ventricular remodeling of heart failure patients with mildly reduced and reduced ejection fraction
    Liuzhang Fan, Lingyun Gu, Yuyu Yao, Genshan Ma · 2022 · Perfusion
  3. Does Heterogeneity Exist in Treatment Associations With Renin–Angiotensin–System Inhibitors or Beta-blockers According to Phenotype Clusters in Heart Failure with Preserved Ejection Fraction?
    Alicia Uijl, Stefan Koudstaal, Davide Stolfo, Ulf Dahlström, Ilonca C. H. Vaartjes, Rick Grobbee, Folkert Wouter Asselbergs, Lars H. Lund, Gianluigi Savarese · 2023 · Journal of Cardiac Failure
  4. Pharmacological Effects of Botanical Drugs on Myocardial Metabolism in Chronic Heart Failure
    Yuxuan Hu, Shenglei Qiu, Juju Shang, Zi Wang, Xiaolei Lai · 2023 · Chinese Journal of Integrative Medicine
  5. Heart Failure with Preserved Ejection Fraction in Brazil: A Systematic Review
    Edimar Alcides Bocchi, Andréa Araújo Brandão, Evandro Tinoco Mesquita, Juliana Sanajotti Nakamuta, André Valente Bichels, Francisco Forestiero · 2023 · ABC Heart Failure & Cardiomyopathy
  6. Comparative efficacy of five traditional Chinese medicine injections for treating heart failure with reduced and mildly reduced ejection fraction: Bayesian network meta-analysis
    Yu Zheng, Huizhen Zheng, Zhihua Guo · 2023 · Heliyon
  7. Rationale and design of the French Observatory of Acute Heart Failure (OFICA2)
    Claire Bouleti, Benjamin Alos, Damien Legallois, Romain Eschalier, JEROME F. COSTA, Victoria Tea, Jean‐Noël Trochu, Guillaume Turlotte, Julie Perrin-Faurie, Téodora Dutoiu et al. · 2024 · Archives of cardiovascular diseases
  8. The year in cardiology 2017: heart failure
    Lars H. Lund, Lars Køber, Karl B Swedberg, Frank Thomas Ruschitzka · 2017 · European Heart Journal
  9. The Current Focus of Heart Failure Clinical Trials
    Naga Venkata K. Pothineni, Ajoe John Kattoor, Swathi Kovelamudi, Satish Kenchaiah · 2018 · Journal of Cardiac Failure
  10. Decrease in loop diuretic treatment from 2005 to 2014 in Swedish real-life patients with chronic heart failure
    Pär Parén, Annika Rosengren, Tatiana Zverkova Sandström, Maria Schaufelberger · 2018 · European Journal of Clinical Pharmacology
  11. Long‐term outcome of hypertensive patients with heart failure with mid‐range ejection fraction: The significance of blood pressure control
    Maria E. Marketou, Spyros Maragkoudakis, Konstantinos Fragkiadakis, John Konstantinou, Alexandros Petros Patrianakos, Spyridon Kassotakis, Ioannis Anastasiou, Afroditi Alevizaki, A. Kostaki, GREGORY I. CHLOUVERAKIS et al. · 2019 · Journal of Clinical Hypertension
  12. Hidden in Heart Failure
    Douglas Ewan Cannie, Mohammed Majid Akhtar, Perry M Elliot · 2019 · European Cardiology Review
  13. Natriuretic peptides for heart failure screening in nursing homes: a systematic review
    Vesna Homar, Špela Miroševič, Igor Švab, Mitja Lainščak · 2020 · Heart Failure Reviews
  14. ARNI and SGLT2i: a promising association to be used with caution.
    Andrea Herbst, Francesco Orso, Marta Migliorini, Simona Virciglio, Silvia Tognelli, Viola Camartini, Alessandra Pratesi, Francesco Fattirolli, Niccolò Marchionni, Andrea Ungar et al. · 2020 · PubMed Central
  15. Efficacy of Dialectical Comprehensive Treatment of Traditional Chinese Medicine in Patients with Chronic Stable Heart Failure: A Randomized Controlled Trial
    Lixiang Yang, Yuanyuan Chen, Fei Lou, Xiaoxia Zhao, Jia Zhou · 2022 · Cardiology Research and Practice
  16. Sodium-Glucose Co-Transporter Type 2 Inhibitors and Heart Failure: A Review of the State of the Art
    Yilmar Alexander Meza-González, Natalia Alfonso-Arrieta, Stephany Salas-Solorzano, Victor Flórez‐García · 2023 · Iberoamerican Journal of Medicine
  17. Vaccination in Heart Failure: An Approach to Improve Outcomes
    Nikolaos P. E. Kadoglou, John Parissis, Petar M Seferovic, Gerasimos S Filippatos · 2018 · Revista Española de Cardiología (English Edition)
  18. Clinical Characteristics, Comorbidities and Prognosis in Patients With Heart Failure With Mid-Range Ejection Fraction
    Ghulam Murtaza, Timir Kumar Paul, Zia Ur Rahman, Danielle Kelvas, Steven J. Lavine · 2020 · The American Journal of the Medical Sciences
  19. Epidemiology of Acutely Decompensated Systolic Heart Failure Over the 2003–2013 Decade in Douala General Hospital, Cameroon
    Daniel Lemogoum, Felicité Kamdem, Bâ Hamadou, William Ngatchou, Guillaume Hye Ndindjock, Anastase Dzudié, Yves Monkam, Sidick Aboubakar Mouliom, Michel Paul Hermans, Elysée Claude Bika Lele et al. · 2020 · ESC Heart Failure
  20. Treatment of Heart Failure With Mid-Range Ejection Fraction: A Summary of Current Evidence
    Teng Ma, Yang Su, Jing Song, Dachun Xu · 2021 · Frontiers in Cardiovascular Medicine
  21. Low dose sacubitril/valsartan is effective and safe in hemodialysis patient with decompensated heart failure and hypotension
    Yunlin Feng, Wenhua Li, Hongjun Liu, Xiuling Chen · 2022 · Medicine
  22. Heart Failure with Mid-Range Ejection Fraction: Causes and Consequences
    Jasper Tromp, Adriaan A. Voors, Carolyn S.P. Lam · 2018 · European Journal of Heart Failure
  23. Clinical Characteristics and Outcomes of Heart Failure with Preserved, Mildly Reduced, and Reduced Ejection Fraction
    Goran Adnan Rahman, Abdulkareem Al-Othman · 2022 · Medical Journal of Babylon
  24. Impacto de la fracción de eyección del ventrículo izquierdo en el consumo de recursos, los costes y el pronóstico en pacientes con insuficiencia cardiaca
    Juan Carlos López‐Azor, Juan F. Delgado, Jorge Íván Bonilla Vélez, Rocío Rodríguez, Jorge Solı́s, Manuel del Oro, Carmen Ortega, Rafael Salguero Bodes, Beatriz Palacios, Lourdes Vicent et al. · 2023 · Revista Española de Cardiología
  25. RNA Sequencing Screens the Key Genes and Pathways in a Mouse Model of HFpEF
    Yuxi Sun, Jiaxin Li, Xinxin Zhang, Ning Wang, Ying Liu · 2024 · Journal of Vascular Research
  26. Heart failure and stroke: The underrepresentation of the heart failure with preserved ejection fraction subtype in randomized clinical trials of therapeutic anticoagulation
    Odysseas Kargiotis, Apostolοs Safouris, Klearchos Psychogios, Gustavo Saposnik, Shadi R. Yaghi, Alexander Eliot Merkler, Hooman Kamel, Gerasimos S Filippatos, Georgios K. Tsivgoulis · 2024 · Journal of the Neurological Sciences
  27. Prognosis of Early-Stage HFpEF in the Community-Dwelling Elderly: The Northern Shanghai Study
    Weilun Meng, Haotian Yang, Zhongyuan Ren, Jiawen Wu, Yixing Zheng, Song Q Zhao, Chong‐Rui Xu, Rusitanmujiang Maimaitiaili, Jiamin Tang, Shikai Yu et al. · 2024 · ESC Heart Failure
  28. Differences in clinical features and 1-year outcomes of patients with heart failure and reduced, mildly reduced, and preserved ejection fraction in a contemporary cohort: is the clinical profile changing?
    María Anguita Gámez, Juan L. Bonilla‐Palomas, Alejandro Recio Mayoral, Rafael González Manzanares, Javier Muñiz, Nieves Romero-Rodríguez, Francisco Javier Elola-Somoza, Angel R. Cequier, Luis Rodrı́guez Padial, Manuel P. Anguita-Sánchez · 2025 · Clinical Research in Cardiology
  29. Integrating the Interleukins in the Biomarker Panel for the Diagnosis and Prognosis of Patients with Acute Coronary Syndromes: Unraveling a Multifaceted Conundrum
    Amalia Stefana Țimpău, Egidia-Gabriela Miftode, Irina-Iuliana Costache-Enache, Antoniu Octavian Petriş, Ionela-Larisa Miftode, Ivona Mitu, Radu-Ştefan Miftode · 2025 · Diagnostics
  30. Predicting Cognitive Impairment in Elderly Patients with HFpEF: Development of a Simple Clinical Risk Score
    Sergiu-Florin Arnăutu, Brenda-Cristiana Bernad, St Gyalai-Korpos I, Mirela Tomescu, Minodora Andor, Dragoş Cătălin Jianu, Diana-Aurora Arnăutu · 2025 · Journal of Clinical Medicine
  31. Coronary Artery Disease in Heart Failure With Preserved Ejection Fraction
    Ryohei Ono, Luiz Menezes Falcão · 2025 · The American Journal of Cardiology
  32. Olink proteomics profiling platform reveals myocardial metabolism-associated protein biomarkers in heart failure with preserved ejection fraction (HFpEF)
    Xinyun Chen, Yimei Huang, Liping Liu, Yuchi Hu, Songyuan Dai, Hongning Li, Chuanxin Li, Siqi Nian, Xi Zhai, Ling Zhao et al. · 2025 · Clinica Chimica Acta
  33. Baseline characteristics of 1,422 patients with heart failure from the HEart failuRe ObsErvational Study of the Polish Cardiac Society (HEROES)
    Maciej Nadel, Martyna Petrykowska-Teysler, Iwona Gorczyca−Michta, Agata Anna Galas, Robert Morawiec · 2025 · Archives of Medical Science
  34. Established and emerging pharmacologic options and unmet needs in HFpEF and HFmrEF
    Andrew J. Sauer, Jozine M. ter Maaten, Gianluigi Savarese · 2026 · ESC Heart Failure
  35. Ablation of PKCα Phosphorylation by CRISPR-Cas9 Base Editing Rescues Heart Failure
    Tomonori Tadokoro, Hui Li, Peiheng Gan, Zhisheng Xu, Wei Hong Tan, Damir Alzhanov, Efrain Sanchez‐Ortiz, John McAnally, Lei Ming Guo, Lori Xu et al. · 2026 · Circulation Research
  36. The ever-growing burden of cardiovascular disease
    Mehmet Birhan Yılmaz, Hakan Güneş · 2021 · Elsevier eBooks
  37. Prognostic association of medication trajectories with 3-year mortality in heart failure and preserved ejection fraction: findings from the EPICAL2 cohort study
    Sarah Bitar, Nathalie Thilly, Nelly Agrinier · 2021 · European Journal of Clinical Pharmacology
  38. Factors Associated with Recurrent Heart Failure during Incorporating SGLT2 Inhibitors in Patients Hospitalized for Acute Decompensated Heart Failure
    Masaki Nakagaito, Teruhiko Imamura, Shuji Joho, Ryuichi Ushijima, Makiko Nakamura, Koichiro Kinugawa · 2022 · Journal of Clinical Medicine
  39. The prediction model of the short-term outcome in elderly heart failure patients
    Mengyu Cao, Yanmin Ju, Di Yang, Huijing Jin, Kexin Zhang, Jiyan Leng · 2023 · Heart Failure Reviews
  40. Prognostic impact of chronic obstructive pulmonary disease in patients with heart failure with mildly reduced ejection fraction
    Felix Lau, Tobias Schupp, Alexander Schmitt, Marielen Reinhardt, Noah Abel, Mohammad Abumayyaleh, Kathrin Weidner, Daniel Duerschmied, Mohamed Ayoub, Kambis Mashayekhi et al. · 2024 · Respiratory Medicine
  41. High initial heart rate score is an independent predictor of new atrial high-rate episodes in pacemaker patients with sinus node dysfunction
    Katsuhide Hayashi, Haruhiko Abe, Brian Olshansky, Arjun D. Sharma, Paul Jones, Nicholas D. Wold, David Perschbacher, Ritsuko Kohno, Gregory Y.H. Lip, Niraj Varma et al. · 2024 · Heart Rhythm
  42. Assessing Static Balance, Balance Confidence, and Fall Rate in Patients with Heart Failure and Preserved Ejection Fraction: A Comprehensive Analysis
    Andriana Teloudi, Maria Anifanti, Konstantinos Chatzinikolaou, George Grouios, Vassilia Hatzitaki, Ioanna Chouvarda, Evangelia Joseph Kouidi · 2024 · Sensors
  43. Rehospitalization, mortality and associated variables in primary care patients with heart failure and preserved ejection fraction after first hospitalization
    Victoria Cendrós-Cámara, Mar Domingo, Elena Navas, Miguel Ángel Muñoz, Antoni Bayés‐Genís, José María Verdú-Rotellar · 2025 · International Journal of Cardiology Cardiovascular Risk and Prevention
  44. Longitudinal Blood Pressure and Cardiovascular Outcomes in Heart Failure: An Individual Patient Data Pooling Analysis of Clinical Trials
    Jing‐Wei Li, Jiang Wang, Yunlong Chen, Hao Yang, Yi Wang, Xia Wang, Jingjng Xiao, Ying Wang, Dehui Qian, Shiyong Yu et al. · 2025 · European Journal of Heart Failure
  45. Prevalence and prognostic impact of abnormal left ventricular ejection fraction in Hemodialysis patients with end-stage renal disease
    Qingkuan Li, Lingyue Qiu, Meiying Long, Huayuan Zeng, Zhihong Lu, Ling Liu, Yingzhong Lin, Kun Ye, Shaoming Qin, Qiuxia Wu et al. · 2025 · BMC Nephrology
  46. Predictors of outcome in patients with de novo diagnosis of heart failure with reduced ejection fraction: Role of combined myocardial and lung Iodine-123 Meta-Iodobenzylguanidine imaging
    Angelo Silverio, Maria Vincenza Polito, Leonardo Pace, Federica D’Auria, Gennaro Vitulano, Massimo Scarano, Rodolfo Citro, Gennaro Galasso, Federico Piscione · 2019 · Journal of Nuclear Cardiology
  47. Sex Differences in Clinical Characteristics and 2-Year Prognosis of Patients with Heart Failure Grouped by Left Ventricular Ejection Fraction Status
    Conglin Wang, Yan Zhou, Rongrong Zhong, Yaping Bao, Zimo Li, Jianli Tian · 2020 · International Heart Journal
  48. Novelties in Therapy of Chronic Heart Failure
    Sara Doimo, Daniela Pavan · 2021 · Heart Failure Clinics
  49. Position of Patients with Mid-Range Ejection Fraction in the General Chronic Heart Failure Population
    Н. Т. Ватутин, A. N. Shevelok, V. V. Venzheha · 2021 · The Russian Archives of Internal Medicine
  50. Pharmacotherapy adherence in patients with heart failure: Easier said than done
    Mitja Lainščak, Daniel Omersa, Giuseppe M.C. Rosano, Jerneja Farkaš, Michael Böhm · 2021 · International Journal of Cardiology
  51. Angiotensin-converting enzyme inhibitors, angiotensin-II-receptor antagonists and angiotensin-receptor blocker/neprilysin inhibitor utilization in heart failure patients: Sub-analysis of a nation-wide population-based study in the Czech Republic
    Renata Aiglová, Miloš Táborský, Marie Lazárová, Luděk Pavlů, Josef Daněk, Jan Přeček, Alexandr Schee, Vít Gloger, Vlastimil Černíček, Marek Vícha et al. · 2021 · Biomedical Papers
  52. Sympathetic Activation in Heart Failure with Reduced and Mildly Reduced Ejection Fraction: The Role of Aetiology
    Réka Urbancsek, Zoltán Csanádi, Ildikó Noémi Forgács, Tímea Bianka Papp, Judit Boczán, Judit Barta, Csaba Jenei, László Nagy, László Rudas · 2021 · ESC Heart Failure
  53. Surgical treatment of patients with aortic valve disease complicated with moderate functional mitral regurgitation and heart failure with midrange ejection fraction: a cohort study
    Wei Zhao, Xieraili Tiemuerniyazi, Yangwu Song, Yifeng Nan, Ziang Yang, Fei Xu, Wei Feng · 2022 · Journal of Thoracic Disease
  54. Vericiguat for the Treatment of Heart Failure with Reduced Ejection Fraction Following a Worsening Heart Failure Event: A Cost-Effectiveness Analysis from the Perspective of Chinese Healthcare Providers
    Xiangyou Yu, Hao Yan, Zhanfang Zhu, Wei Zhang, Bo Liu, Meijuan Ma, Xuejun Zhang, Na Wei, Junkui Wang, Fuqiang Liu · 2023 · Clinical Drug Investigation
  55. Heart Failure Outcomes by Left Ventricular Ejection Fraction in a Contemporary Region-Wide Patient Cohort
    Johan Sundström, Johan Ärnlöv, Stelios Karayiannides, Johan Bodegård, Karolina Ersmark, Stefan Gustafsson, Thomas Cars, Maria K Eriksson Svensson, Anna Norhammar · 2024 · ESC Heart Failure
  56. Effect of severity and etiology of chronic kidney disease in patients with heart failure with mildly reduced ejection fraction
    Tobias Schupp, Kathrin Weidner, Felix Lau, Jan Forner, Alexander Schmitt, Marielen Reinhardt, Noah Abel, Niklas Ayasse, Thomas Bertsch, Muharrem Akin et al. · 2024 · Clinical Research in Cardiology
  57. Development and validation of a nomogram model for all-cause mortality risk in patients with chronic heart failure and atrial fibrillation
    Lin Guan, Chuan-He Wang, Hao Sun, Zhi-Jun Sun · 2024 · BMC Geriatrics
  58. Decompensated Heart Failure with Mid-Range Ejection Fraction: Epidemiology and In-Hospital Mortality Risk Factors
    Gabriela Paiva Cavalcanti, Camila Sarteschi, Glory Eithne Sarinho Gomes, Carolina de Araújo Medeiros, José Henrique Martins Pimentel, André Rabelo Lafayette, Maria Celita de Almeida, Paulo Sérgio Rodrigues Oliveira, Sílvia Marinho Martins · 2019 · International Journal of Cardiovascular Sciences
  59. Impact du programme d'aide au retour à domicile-insuffisance cardiaque (PRADO-IC) sur la mortalité et la réhospitalisation à un an dans une population de patients insuffisants cardiaques
    Philippe Abassade, Léa Cohen, Audrey Fels, Gilles Châtellier, Emmanuelle Sacco, Hélène Beaussier, Laetitia Fleury, Michel Komajda N, Romain Cador · 2022 · Annales de Cardiologie et d Angéiologie
  60. Acute heart failure in the elderly: setting related differences in clinical features and management.
    Francesco Orso, Alessandra Pratesi, Andrea Herbst, Anna Chiara Baroncini, Francesca Bacci, Gabriele Ciuti, Andrea Berni, Camilla Tozzetti, Carlo Nozzoli, Alberto Moggi Pignone et al. · 2021 · PubMed Central
  61. Outcomes of patients with heart failure followed in units accredited by the SEC-Excelente-IC quality program according to the type of unit
    María Anguita Gámez, Juan Luis Bonilla Palomas, Alejandro Recio Mayoral, Rafael González Manzanares, Javier Muñiz, Nieves Romero-Rodríguez, Francisco Javier Elola Somoza, Angel R. Cequier, Luis Rodrı́guez Padial, Manuel Anguita Sánchez · 2024 · Revista Española de Cardiología (English Edition)
  62. Atrial Functional Mitral Regurgitation: Definition, Mechanisms, and Treatment Perspectives
    Sebastiaan Dhont, Sébastien Deferm, Philippe B. Bertrand, Pieter M. Vandervoort · 2025 · Current Cardiology Reports
  63. Serum Levels of Irisin Are Positively Associated with Improved Cardiac Function in Patients with Heart Failure with Reduced Ejection Fraction
    Alexander Е. Berezin, Tetiana A. Berezina, Evgen V. Novikov, Oleksandr O. Berezin · 2025 · Biomedicines
  64. A web-based dynamic nomogram for predicting readmission in patients with heart failure with preserved ejection fraction
    Yi Ji, Guodong Wang, Yue Hu, Xiaotong Wang, Wanling Wu, Yuanyuan Luo, Yanqing Pan, Jie Liu, Lei Li, Hong Zhu et al. · 2025 · Frontiers in Cardiovascular Medicine
  65. Association of Different Types of Diabetic Autonomic Neuropathy With Left Ventricular Diastolic Dysfunction in Patients With Type 2 Diabetes: A Cross‐Sectional Study
    Ruixue Feng, Donge Yan, Mingxin Bai, Xingwu Ran, Dawei Chen, Chun Wang, Lihong Chen, Shuang Lin, Sen He, Yan Liu et al. · 2025 · Journal of Diabetes
  66. A predictive model for heart failure with preserved ejection fraction following acute myocardial infarction: the HFpEF-AMI score
    Xi Wu, Mingxing Wu, Haobo Huang, Zhe Liu, He Huang, Lei Wang · 2025 · BMC Cardiovascular Disorders
  67. The effect of guideline-directed medicine on patients with new-onset heart failure following acute myocardial infarction
    Mengjie Lei, Jingyao Wang, Xiao Wang, Xue Sue, Cairong Li, Yanli Yang, Yachao Li, Zhigang Zhao, Zengming Xue · 2025 · Frontiers in Cardiovascular Medicine
  68. Epidemiology and Burden of Heart Failure
    Zhaoxu Jia, Xin Du · 2025 · Cardiology Discovery
  69. Phenotypes and Clinical Outcome of Heart Failure With Preserved Ejection Fraction Patients in China: Findings From the Chinese Cardiovascular Association Database‐Heart Failure Center Registry
    Shuai Yuan, Zhonglei Xie, Xiaotong Cui, Shun Yao, Yamei Xu, Yanyan Wang, Yu Song, Kai Hu, Yugang Dong, Yuhua Liao et al. · 2026 · MedComm
  70. Pulmonary artery denervation improves left ventricular diastolic function in patients with isolated post-capillary pulmonary hypertension secondary to heart failure with preserved ejection fraction: a safety and proof-of-principle cohort study
    Xiaomin Jiang, Hang Zhang, Juan Zhang, Yue Gu, Dujiang Xie, Zhimei Wang, Shao-Liang Chen · 2026 · AsiaIntervention
  71. Factors associated with risk analysis for asymptomatic left ventricular diastolic dysfunction in nondialysis patients with chronic kidney disease
    Yajuan Gao, Shengnan Chen, Jiani Fu, Cui Wang, Yali Tang, Yongbai Luo, Xiaozhen Zhuo, Xueying Chen, Yan Shen · 2024 · Renal Failure
  72. Inotropic Agents: Are We Still in the Middle of Nowhere?
    Anna Maria Iorio, Fabiana Lucà, Andrea Pozzi, Carmelo Massimiliano Rao, Stefania Angela Di Fusco, Furio Colivicchi, Massimo Grimaldi, Fabrizio Giovanni Oliva, Michele Massimo Gulizia · 2024 · Journal of Clinical Medicine
  73. Characteristics of the phenotypes in prevalent and incident cases of heart failure in primary care: IBERICAN study
    Sergio Cinza‐Sanjurjo, Miguel Ángel Prieto-Díaz, Vicente Pallarés‐Carratalá, Rafael Manuel Micó-Pérez, Sonsoles M. Velilla-Zancada, Alfonso Barquilla-García, Leovigildo Ginel-Mendoza, Antonio Segura‐Fragoso, Vicente Martín, José Polo García · 2024 · BMC Family Practice
  74. Combination of C-reactive protein and fibrinogen-to-albumin ratio as a novel predictor of all-cause mortality in heart failure patients
    Sirui Yang, Hongyan Cai, Zhao Y. Hu, Wei Huang, Qin Fu, Ping Xia, Wenyi Gu, Tao Shi, Fazhi Yang, Lixing Chen · 2024 · Open Medicine
  75. SỬ DỤNG THUỐC ỨC CHẾ SGLT2 Ở BỆNH NHÂN SUY TIM MẠN PHÂN SUẤT TỐNG MÁU GIẢM THEO KHUYẾN CÁO CỦA HỘI TIM MẠCH HỌC VIỆT NAM 2022
    Xuân Tiến Mai, Kim Trang Trần, Mạnh nhân Vũ · 2025 · Tạp chí Y học Việt Nam
  76. Clinical characteristics, predictors of mortality, and outcome in patients with heart failure with mildly reduced ejection fraction secondary to Chagas cardiomyopathy
    Reinaldo B. Bestetti, Ana Paula Otaviano, Augusto Cardinalli-Neto, Maurício de Nassau Machado, Marcelo Arruda Nakazone · 2025 · International Journal of Cardiology
  77. Findings Across the Ejection Fraction Subgroups in Hospitalised Heart Failure Patients: The First MY-HF Registry Study
    Wan Azman Wan Ahmad, Abdul Kahar Abdul Ghapar, Azmee Mohd Ghazi, H.A. Zainal, Noel Thomas Ross, W. Yus Haniff W. Isa, Tamil Selvan Muthusamy, A.M. Abd Malek, Mohd Sapawi Mohamed, Firdaus Mat Lawi et al. · 2025 · Journal of Asian Pacific Society of Cardiology
  78. Modulation of GLP-1 signalling as an innovative strategy counteracting the onset of heart failure: Potential for natural compound supplementation
    Micaela Gliozzi, Anna Rita Coppoletta, Antonio Cardamone, Cristina Carresi, Rocco Mollace, Vincenzo Musolino, Vincenzo Mollace · 2025 · Pharmacological Research
  79. Development and validation of risk stratification and shared decision-making tool for catheter ablation for atrial fibrillation in patients with heart failure: a multicentre cohort study
    Xiaodong Peng, Liu He, Jue Wang, Nan Li, Jing Cui, Shijun Xia, Song Zuo, Chao Qiang Jiang, Jinzhu Hu, Kui Hong et al. · 2025 · EClinicalMedicine
  80. Clinical Profiles in Acute Heart Failure: One Size Fits all or Not at All?
    Andrew P. Ambrosy, Mihai Gheorghiade · 2017 · European Journal of Heart Failure
  81. ESC Heart Failure Receives its First Impact Factor
    Markus S. Anker, Stephan von Haehling, Zoltán Papp, Stefan D. Anker · 2019 · European Journal of Heart Failure
  82. Tratamiento farmacológico de la insuficiencia cardíaca según la fracción de eyección ventricular en atención primaria
    Maria Giner‐Soriano, Dioselina Díaz Baena, Dan Ouchi, Ainhoa Gómez-Lumbreras, Rosa Morros · 2022 · Atención Primaria
  83. Functional Classification versus Ejection Fraction in Patients with Heart Failure and Chagas Disease
    Joseylton Gonçalves Santana, Marcela Gordilho Aras, Luca Nascimento, Roque Aras · 2021
  84. Clinical Validation of an Artificial Intelligence–Based Tool for Automatic Estimation of Left Ventricular Ejection Fraction and Strain in Echocardiography: Protocol for a Two-Phase Prospective Cohort Study
    Stelios Hadjidimitriou, Efstathios D. Pagourelias, Georgios K. Apostolidis, Ioannis Dimaridis, Vasileios S. Charisis, Constantinos Bakogiannis, Leontios J. Hadjileontiadis, Vassilios Pericles Vassilikos · 2023 · JMIR Research Protocols
  85. Arrythmia-Mediated Valvular Heart Disease
    Sébastien Deferm, Philippe B. Bertrand, Sebastiaan Dhont, Ralph Stephan von Bardeleben, Pieter M. Vandervoort · 2023 · Heart Failure Clinics
  86. Ejection fraction at hospital admission stratifies mortality risk in HFmrEF patients aged ≥ 70 years: a retrospective analysis from a tertiary university institution
    Andrea Sonaglioni, Chiara Lonati, Marta Teresa Behring, Gian Luigi Nicolosi, Michele Lombardo, Sergio Alfonso Harari · 2023 · Aging Clinical and Experimental Research
  87. The correlation of left atrial diameter with preserved ejection fraction, reduced ejection fraction, and mid‐range ejection fraction
    Jing Lin, Huajui Wu, Tianwen Zhang · 2023 · Clinical Cardiology
  88. Clinical efficacy of angiotensin receptor-neprilysin inhibitor in de novo heart failure with reduced ejection fraction
    Su Yeong Park, Min Gyu Kong, Inki Moon, Hyun Woo Park, Hyung-Oh Choi, Hye–Sun Seo, Yoon Haeng Cho, Nae‐Hee Lee, Kwan Yong Lee, Ho‐Jun Jang et al. · 2023 · The Korean Journal of Internal Medicine
  89. The ‘Peptide for Life’ Initiative in the Emergency Department Study
    Antoni Bayés‐Genís, Gordana Krljanać, Marija D. Zdravkovic, Milika Ašanin, Anastazija Stojšić‐Milosavljević, Slavica Radovanović, Tamara Kovacevic, Aleksandar Selaković, Ivan Milinković, Marija M. Polovina et al. · 2023 · ESC Heart Failure
  90. Impact of Coronary Microvascular Dysfunction on Myocardial Strain in Patients with Heart Failure and Preserved Ejection Fraction
    Mohamed Yahia, Ahmed Emara, Waleed Abdou, MohamedFouad Ewis · 2023 · Journal of Cardiovascular Echography
  91. An Update on the Prevalence of Heart Failure
    Tomasz Roman Zdrojewski · 2023 · Updates in hypertension and cardiovascular protection
  92. Clinical Characteristics and Outcomes of Patients with Heart Failure of Hypertensive Etiology: Analysis of Colombian Heart Failure Registry (RECOLFACA)
    Erika M. Martínez-Carreño, Luis Eduardo Echeverría, Alex Arnulfo Rivera-Toquica, Mario Zarama, Elkin Giovanni Ramírez-Puentes, Rafael Ignacio Bustamante, Rolando Palacio, Luis Manuel Ávila-Barros, Sebastián Campbell‐Quintero, Lisbeth Natalia Morales-Rodríguez et al. · 2024 · Kidney & Blood Pressure Research
  93. Pronóstico de los pacientes con insuficiencia cardiaca seguidos en unidades acreditadas en el programa SEC-Excelente-IC con relación al tipo de unidad
    María Anguita Gámez, Juan Luis Bonilla Palomas, Alejandro Recio Mayoral, Rafael González Manzanares, Javier Muñiz García, Nieves Romero-Rodríguez, Francisco Javier Elola Somoza, Angel R. Cequier, Luis Rodrı́guez Padial, Manuel Anguita Sánchez · 2024 · Revista Española de Cardiología
  94. Comparing antihypertensive strategies in hypertensive emergencies with heart failure
    David Bronstein, Michael Holman, Ryan Wu, Jeremy Hayward, Zeina Bani Hani, Courtney Paul, Katrina Hawkins · 2024 · The American Journal of Emergency Medicine
  95. Heart Failure Patients’ Perceptions of Received and Wanted Information: A Cross-Sectional Study
    Lena Andersson, Lena Nordgren · 2018 · Clinical Nursing Research
  96. The role of TAVR in patients with heart failure: do we have the responses to all questions?
    Marijana Vaso Tadic, Carla Sala, Cesare Cuspidi · 2022 · Heart Failure Reviews
  97. Impact of Hyperkalemia in Heart Failure and Reduced Ejection Fraction: A Retrospective Study
    Andrea López‐López, Raúl Franco‐Gutiérrez, Alberto J. Pérez-Pérez, Margarita Regueiro‐Abel, Juliana Elices‐Teja, Charigan Abou-Jokh, Carlos González‐Juanatey · 2023 · Journal of Clinical Medicine
  98. Efficacy and safety of atrial fibrillation ablation in heart failure patients with left ventricular ejection fraction less than 50%
    Yusuke Sakamoto, Hiroyuki Osanai, Yuichiro Sakai, Yoshiki Sogo, Yuki Tanaka, Shotaro Hiramatsu, Hikari Matsumoto, Ken Tomooka, Kenji Arai, Takashi Watanabe et al. · 2023 · Indian Pacing and Electrophysiology Journal
  99. First-phase ejection fraction to predict adverse outcomes in patients with heart failure
    Chunna Jin, Guanzhong Chen, Senmiao Chen, Chengchen Zhao, Yufeng Wu, Liuguang Song, Tingting Zhao, Yao Xie, Hong Ma, Meixiang Xiang · 2023 · International Journal of Cardiology
  100. Efficacy and safety of sacubitril/valsartan after six months in patients with heart failure with reduced ejection fraction and asymptomatic hypotension
    Anhu Wu, Zongwei Lin, Zhuohao Yang, Hui Zhang, Jiayi Hu, Yi WANG, Rui TANG, Xinyu Zhang, Xiaoping Ji, Huixia Lu · 2023 · 老年心脏病学杂志:英文版